This business is currently listed for sale.
Rescrito
AI Writing Assistant for students and researchers
Est. Valuation
$424.4K
$424,440 · 5× ARR estimate
Monthly Revenue (MRR)
$7.1K
$7,074/mo
Annual Revenue (ARR)
$84.9K
$84,888/yr
Founded
2024
Rescrito Revenue History
Revenue history for Rescrito from 2026 to 2026.
| Year | MRR | ARR | YoY Growth | Source |
|---|---|---|---|---|
| 2026 | $7,074 | $84,888 | — | Apr 2026 |
How Rescrito Makes Money
Free: Trial available, Monthly: 8.99€, Quarterly: 6.99€, Annual: 4.99€
Rescrito Funding
Rescrito is fully bootstrapped with no outside funding. The company has grown to $84,888 ARR organically.
Rescrito FAQ
How much does Rescrito make?
What is Rescrito's valuation?
Is Rescrito bootstrapped?
Is Rescrito for sale?
Companies Similar to Rescrito
SaaS companies with similar tags and business models.
How We Estimate Rescrito's Revenue & Valuation
Profitable tracks revenue, valuation, and other key metrics for thousands of companies using a layered confidence model. Each revenue figure on this page is tagged with one of three confidence levels:
- Verified — directly confirmed via Stripe integration or audited filings.
- Self-reported — numbers publicly shared by the founder on X, blog posts, or interviews.
- Estimated — derived from publicly available signals (traffic, employee count, pricing, comparables).
Valuation follows a hierarchy: public companies use the live market cap; private companies with disclosed funding rounds use the last reported valuation; otherwise we apply a conservative 5× ARR multiple as an estimate. Multiples vary by business model — SaaS typically sits 5–7×, profitable bootstrapped operations 3–5×, consumer brands 1–3×, marketplaces 8–12×.
These are estimates, not official figures. Official numbers — when available — will always override estimates.